Join to view full profile
6560 Fannin StreetSuite 802Houston, TX 77030
Phone+1 713-441-3780
Fax+1 713-790-5079
Dr. Simpson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Neurology, 1996 - 1999- Baylor College of MedicineInternship, Internal Medicine, 1995 - 1996
McGovern Medical School at UTHealthClass of 1995
Certifications & Licensure
TX State Medical License 1997 - 2028
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- Top MD Consumers Checkbook
Clinical Trials
Publications & Presentations
PubMed
- Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.Valeria A Sansone, Andrea Lizio, Carola R Ferrari Aggradi, Lucia C Greco, Cynthia Gagnon
Muscle & Nerve. 2026-07-01 - 3 citationsA transdisciplinary dual degree curriculum yields novel and successful learning outcomes: early lessons from training physicianeers.Gregg B Wells, Douglas A Baxter, Leslie J Day, Timothy B Boone, Michael R Moreno
Frontiers in Medicine. 2025-01-01 - 2 citationsEstablishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.Karlien Mul, Kate Eichinger, Man Hung, Valeria A Sansone, Cynthia Gagnon
Plos One. 2025-01-01
Press Mentions
Neurology Questions? Ask the Experts at Houston Methodist Q&A SessionOctober 16th, 2018
Stem Cells Deemed Safe for ALS PatientsJune 29th, 2016
New ALS Drug Headed for Phase II TrialOctober 25th, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
